Target intelligence / Profile preview

Oculomotor nerve (CN III)

Target
CN III
Molecular classification
Other
01

Overview

The oculomotor nerve (cranial nerve III) is a complex anatomical structure originating from the midbrain that serves both somatic motor and autonomic functions for the eye. It provides motor innervation to the superior, medial, and inferior recti, the inferior oblique muscle, and the levator palpebrae superioris, which are essential for coordinated eye movement and eyelid elevation [StatPearls, NBK541103]. Additionally, it carries parasympathetic fibers from the Edinger-Westphal nucleus that synapse in the ciliary ganglion to regulate the pupillary sphincter and ciliary muscles, controlling light entry and lens accommodation [NIH, NBK537159]. While not a molecular target itself, the nerve's signaling pathways—specifically the cholinergic transmission at the neuromuscular junction and post-ganglionic parasympathetic synapses—are the sites of action for various drugs such as botulinum toxin and muscarinic agents. Pathological involvement of the nerve is a critical clinical finding in conditions ranging from diabetic mononeuropathy to life-threatening aneurysms, typically manifesting as diplopia, ptosis, and pupillary dilation.

Other names
Cranial nerve IIIThird cranial nerveNervus oculomotoriusCNIII
02

Mechanism of action

Pharmacological agents interact with the oculomotor nerve pathway primarily by modulating cholinergic transmission. This includes inhibiting acetylcholine release at the neuromuscular junction (e.g., Botulinum toxin) or acting as agonists/antagonists at nicotinic receptors on the extraocular muscles and muscarinic receptors on the pupillary sphincter and ciliary body [StatPearls, NBK541103].

03

Biological functions

Extraocular muscle contractionEyelid elevationPupillary constriction (Miosis)Lens accommodation
04

Disease associations

Oculomotor nerve palsyPtosisMydriasisWeber syndromeCavernous sinus syndromeDiabetic mononeuropathyAneurysm (Posterior communicating artery)
05

Safety considerations

Diplopia (double vision)Ptosis (eyelid drooping)Fixed dilated pupil (Mydriasis)Loss of accommodation (blurred near vision)Iatrogenic injury during neurosurgery
06

Interacting drugs

Botulinum toxin A

5 more in the full profile.

07

Biomarkers

Pupillary light reflexExtraocular motility (H-test)Marginal reflex distance (MRD1) for ptosisMagnetic resonance imaging (MRI) of the midbrain and orbit

Beyond the preview

Go deeper on Oculomotor nerve (CN III).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Oculomotor nerve (CN III).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call